April 29, 2020 / 8:29 PM / in a month

BRIEF-Jazz Pharma Stops Enrollment In Phase 3 Study Evaluating Defibrotide For Prevention Of Veno-Occlusive Disease

April 29 (Reuters) - Jazz Pharmaceuticals PLC:

* JAZZ PHARMACEUTICALS STOPS ENROLLMENT IN PHASE 3 STUDY EVALUATING DEFIBROTIDE FOR PREVENTION OF VENO-OCCLUSIVE DISEASE

* JAZZ PHARMACEUTICALS PLC - ENROLLMENT IN PHASE 3 STUDY WAS STOPPED EARLY BASED ON RECOMMENDATION FROM AN INDEPENDENT DATA MONITORING COMMITTEE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below